Tri Locum Partners’s Idexx Laboratories IDXX Stock Holding History

Tri Locum Partners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-44,972	Closed	-$18.6M	–	27
2024 Q4	$18.6M	Buy	+44,972	New	+$19.7M	3.85%	12

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Tri Locum Partners's IDXX Position: Q1 2025 in Review

Tri Locum Partners sold out of Idexx Laboratories (IDXX) in Q1 2025, closing a stake of 44,972 shares — an estimated $18.6M sold.

Tri Locum Partners first reported a position in IDXX in Q4 2024 and held it in 1 quarter. The position peaked at $18.6M in Q4 2024. 1,142 funds tracked by Wall St. Rank hold IDXX as of Q1 2025.

Tri Locum Partners reported no remaining Idexx Laboratories position as of Q1 2025 after selling out during the quarter.
Tri Locum Partners sold 44,972 Idexx Laboratories shares in Q1 2025, an estimated $18.6M.
Tri Locum Partners first reported a position in Idexx Laboratories in Q4 2024 and held it in 1 quarter.
Tri Locum Partners's Idexx Laboratories position peaked at $18.6M in Q4 2024.
1,142 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2025.

Based on Tri Locum Partners's 13F filing for Q1 2025, filed 14 May 2025.